Sichuan Sheng Tong Yuan Pharmaceutical Group Co., Ltd. romanized

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.

Accepted: 5 applicationsNo longer listed under review: 7 applicationsSupplement delivery: 7 applications

1. 2026/11/06No longer listed under review

   炙甘草合剂 · No verified English name

   CYZB2603485

   Fact date: 2026/11/06 · Site observation date: 2026/11/06

   Accepted: 2026/07/16

   not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/04); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 67

   NMPA · Table row 67 ↗ View source ↗
2. 2026/11/06No longer listed under review

   除湿止痒洗液 · No verified English name

   CYZB2603164

   Fact date: 2026/11/06 · Site observation date: 2026/11/06

   Accepted: 2026/07/03

   not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/04); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 54

   NMPA · Table row 54 ↗ View source ↗
3. 2026/11/05No longer listed under review

   止咳平喘糖浆 · No verified English name

   CYZB2603020

   Fact date: 2026/11/05 · Site observation date: 2026/11/05

   Accepted: 2026/06/26

   not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/11/04 (approval no.: —; approval date: 2026/11/03); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 4

   NMPA · Table row 4 ↗ View source ↗
4. 2026/11/04Supplement delivery

   炙甘草合剂 · No verified English name

   CYZB2603485

   Fact date: 2026/11/04 · Publication date: 2026/11/06 · Site observation date: 2026/11/06

   Supplemental application; excluded from new marketing approvals.

   View source · Table row 67 ↗
5. 2026/11/04Supplement delivery

   除湿止痒洗液 · No verified English name

   CYZB2603164

   Fact date: 2026/11/04 · Publication date: 2026/11/06 · Site observation date: 2026/11/06

   Supplemental application; excluded from new marketing approvals.

   View source · Table row 54 ↗
6. 2026/11/03Supplement delivery

   止咳平喘糖浆 · No verified English name

   CYZB2603020

   Fact date: 2026/11/03 · Publication date: 2026/11/04 · Site observation date: 2026/11/04

   Supplemental application; excluded from new marketing approvals.

   View source · Table row 4 ↗
7. 2026/10/29No longer listed under review

   十滴水 · No verified English name

   CYZB2603166

   Fact date: 2026/10/29 · Site observation date: 2026/10/29

   Accepted: 2026/07/03

   not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/10/29 (approval no.: —; approval date: 2026/10/27); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 26

   NMPA · Table row 26 ↗ View source ↗
8. 2026/10/27Supplement delivery

   十滴水 · No verified English name

   CYZB2603166

   Fact date: 2026/10/27 · Publication date: 2026/10/29 · Site observation date: 2026/11/03

   Supplemental application; excluded from new marketing approvals.

   View source · Table row 26 ↗
9. 2026/10/23No longer listed under review

   肝得治胶囊 · No verified English name

   CYZB2603770

   Fact date: 2026/10/23 · Site observation date: 2026/10/23

   Accepted: 2026/07/30

   not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/10/23 (approval no.: —; approval date: 2026/10/21); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 117

   NMPA · Table row 117 ↗ View source ↗
10. 2026/10/23No longer listed under review

    保心宁胶囊 · No verified English name

    CYZB2603769

    Fact date: 2026/10/23 · Site observation date: 2026/10/23

    Accepted: 2026/07/30

    not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/10/23 (approval no.: —; approval date: 2026/10/21); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 116

    NMPA · Table row 116 ↗ View source ↗
11. 2026/10/23No longer listed under review

    金钱草胶囊 · No verified English name

    CYZB2603482

    Fact date: 2026/10/23 · Site observation date: 2026/10/23

    Accepted: 2026/07/16

    not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/10/23 (approval no.: —; approval date: 2026/10/21); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 81

    NMPA · Table row 81 ↗ View source ↗
12. 2026/10/21Supplement delivery

    肝得治胶囊 · No verified English name

    CYZB2603770

    Fact date: 2026/10/21 · Publication date: 2026/10/23 · Site observation date: 2026/11/03

    Supplemental application; excluded from new marketing approvals.

    View source · Table row 117 ↗
13. 2026/10/21Supplement delivery

    保心宁胶囊 · No verified English name

    CYZB2603769

    Fact date: 2026/10/21 · Publication date: 2026/10/23 · Site observation date: 2026/11/03

    Supplemental application; excluded from new marketing approvals.

    View source · Table row 116 ↗
14. 2026/10/21Supplement delivery

    金钱草胶囊 · No verified English name

    CYZB2603482

    Fact date: 2026/10/21 · Publication date: 2026/10/23 · Site observation date: 2026/11/03

    Supplemental application; excluded from new marketing approvals.

    View source · Table row 81 ↗
15. 2026/09/01Accepted

    藿香正气胶囊 · No verified English name

    CYZB2604447

    Fact date: 2026/09/01 · Site observation date: 2026/10/22

    View source ↗
16. 2026/08/31Accepted

    复方岗松洗液 · No verified English name

    CYZB2604430

    Fact date: 2026/08/31 · Site observation date: 2026/10/22

    View source ↗
17. 2026/08/20Accepted

    复方黄连素片 · No verified English name

    CYZB2604270

    Fact date: 2026/08/20 · Site observation date: 2026/10/22

    View source ↗
18. 2026/08/18Accepted

    安胃颗粒 · No verified English name

    CYZB2604213

    Fact date: 2026/08/18 · Site observation date: 2026/10/22

    View source ↗
19. 2026/08/18Accepted

    肾康宁片 · No verified English name

    CYZB2604212

    Fact date: 2026/08/18 · Site observation date: 2026/10/22

    View source ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

CDE acceptances and review

Last successful update: 2026/11/13 06:42

Chemical-drug catalogue

Last successful update: 2026/11/13 06:39

Full API register

Last successful update: 2026/11/13 06:41

NMPA drug delivery notices

Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete

First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.

Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.

Public drug landscapes ↗